|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nagaiah G, Hossain A, Mooney CJ,
Parmentier J and Remick SC: Anaplastic thyroid cancer: A review of
epidemiology, pathogenesis, and treatment. J Oncol 2011.
5423582011.
|
|
3
|
O'Neill JP and Shaha AR: Anaplastic
thyroid cancer. Oral Oncol. 49:702–706. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fuziwara CS and Kimura ET: MicroRNAs in
thyroid development, function and tumorigenesis. Mol Cell
Endocrinol. 456:44–50. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rosignolo F, Memeo L, Monzani F, Colarossi
C, Pecce V, Verrienti A, Durante C, Grani G, Lamartina L, Forte S,
et al: MicroRNA-based molecular classification of papillary thyroid
carcinoma. Int J Oncol. 50:1767–1777. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Boufraqech M, Klubo-Gwiezdzinska J and
Kebebew E: MicroRNAs in the thyroid. Best Pract Res Clin Endocrinol
Metab. 30:603–619. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Celano M, Rosignolo F, Maggisano V, Pecce
V, Iannone M, Russo D and Bulotta S: MicroRNAs as biomarkers in
thyroid carcinoma. Int J Genomics 2017. 64965702017.
|
|
9
|
Wang X, Jin Y, Zhang H, Huang X, Zhang Y
and Zhu J: MicroRNA-599 inhibits metastasis and
epithelial-mesenchymal transition via targeting EIF5A2 in gastric
cancer. Biomed Pharmacother. 97:473–480. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xie B, Zhang C, Kang K and Jiang S:
miR-599 inhibits vascular smooth muscle cells proliferation and
migration by targeting TGFB2. PLoS One. 10:e01415122015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nelson KM and Weiss GJ: MicroRNAs and
cancer: Past, present, and potential future. Mol Cancer Ther.
7:3655–3660. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang Y, Sui Y, Zhu Q and Sui X:
Hsa-miR-599 suppresses the migration and invasion by targeting BRD4
in breast cancer. Oncol Lett. 14:3455–3462. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang T, Ma G, Zhang Y, Huo H and Zhao Y:
miR-599 inhibits proliferation and invasion of glioma by targeting
periostin. Biotechnol Lett. 39:1325–1333. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tian W, Wang G, Liu Y, Huang Z, Zhang C,
Ning K, Yu C, Shen Y, Wang M, Li Y, et al: The miR-599 promotes
non-small cell lung cancer cell invasion via SATB2. Biochem Biophys
Res Commun. 485:35–40. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tian J, Hu X, Gao W, Zhang J, Chen M,
Zhang X, Ma J and Yuan H: Identification a novel tumor-suppressive
hsa-miR-599 regulates cells proliferation, migration and invasion
by targeting oncogenic MYC in hepatocellular carcinoma. Am J Transl
Res. 8:2575–2584. 2016.PubMed/NCBI
|
|
16
|
Sánchez-Jiménez C and Izquierdo JM: T-cell
intracellular antigens in health and disease. Cell Cycle.
14:2033–2043. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Reyes R, Alcalde J and Izquierdo JM:
Depletion of T-cell intracellular antigen proteins promotes cell
proliferation. Genome Biol. 10:R872009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Izquierdo JM, Alcalde J, Carrascoso I,
Reyes R and Ludeña MD: Knockdown of T-cell intracellular antigens
triggers cell proliferation, invasion and tumour growth. Biochem J.
435:337–344. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hamdollah Zadeh MA, Amin EM,
Hoareau-Aveilla C, Domingo E, Symonds KE, Ye X, Heesom KJ, Salmon
A, D'Silva O, Betteridge KB, et al: Alternative splicing of TIA-1
in human colon cancer regulates VEGF isoform expression,
angiogenesis, tumour growth and bevacizumab resistance. Mol Oncol.
9:167–178. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu Y, Liu R, Yang F, Cheng R, Chen X, Cui
S, Gu Y, Sun W, You C, Liu Z, et al: miR-19a promotes colorectal
cancer proliferation and migration by targeting TIA1. Mol Cancer.
16:532017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hamada J, Shoda K, Masuda K, Fujita Y,
Naruto T, Kohmoto T, Miyakami Y, Watanabe M, Kudo Y, Fujiwara H, et
al: Tumor-promoting function and prognostic significance of the
RNA-binding protein T-cell intracellular antigen-1 in esophageal
squamous cell carcinoma. Oncotarget. 7:17111–17128. 2016.
View Article : Google Scholar : PubMed/NCBI
|
